Bioventures Investors — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
3DBiopsyMay 2022SEC filingmedium confidence
Aurora, US
Brad Buscher(Executive Officer, Director)Nelson Stone(Founder)E. David Crawford(Founder)
Board seatJames Lousararian· per SEC Form D · $500K raise · filed Jun 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.